Table 3.
Comparative analysis of ApoEVs vs. canonical osteogenic proteins/growth factors in bone healing
| Comparison dimension | Apoptotic extracellular vesicles (ApoEVs) | Canonical osteogenic proteins/growth factors | Ref. |
|---|---|---|---|
| Signal structure & cargo | Membrane-encapsulated, multimodal carriers that act as integrated “information packages,” capable of co-delivering proteins, lipids, and nucleic acids simultaneously | Primarily soluble proteins (e.g., BMPs, TGF-β, IGFs, FGFs, PDGFs, VEGF) or pathway ligands (e.g., Wnts) that signal through their cognate cell-surface receptors | [86, 110, 115] |
| Multiplexing & pathway coverage | High intrinsic multiplexing potential: a single vesicle can carry multiple bioactive cues to coordinate diverse cellular programs, including immune modulation, matrix remodeling, osteogenesis, and angiogenesis-osteogenesis coupling | Typically act in a module- or pathway-specific manner. Broader niche coordination requires the sequential action of multiple factors within a network | |
| Spatiotemporal availability | Injury-coupled production: generated locally in damaged tissues during repair/remodeling, as part of apoptosis and subsequent cellular clearance processes | Availability is governed by endogenous expression, release, diffusion, and degradation kinetics. Exogenous supplementation requires controlled delivery to achieve therapeutic timing and localization | |
| Delivery & engineering | The bilayer membrane structure protects cargo and supports direct intercellular transfer. Conceptually well-suited for engineering strategies to enable targeted delivery or depot-based release | Soluble proteins often require additional carriers or depot systems to enhance local retention and dose control. Diffusion and rapid clearance can limit effective therapeutic exposure | |
| Standardization & quality control | Demands rigorous standardization across the entire workflow: from defining the source material, inducing apoptosis, isolating vesicles, and characterizing them (including distinguishing them from EVs released by viable cells) | Molecular identity is well-defined and easily quantifiable. However, biological outcomes are highly dependent on dose, timing, and local presentation, often requiring specialized delivery systems for spatiotemporal control in repair settings |